An investigation of the artificial chromosome expression system for production of recombinant proteins
The requirement to produce complex, therapeutic proteins that possess human-like post-translational modifications for treatment of disease has accelerated the use of mammalian cell lines, in particular Chinese hamster ovary (CHO) cells, in the biopharmaceutical industry. However, producing stable, h...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.632094 |